The North America Protein Hydrolysis Enzymes Market would witness market growth of 5.7% CAGR during the forecast period (2022-2028).
The rate and effectiveness of protein digestion, as well as the subsequent amino acid absorption, are reduced in the aged. It has been hypothesized that eating protein hydrolysates rather than intact protein would hasten protein digestion and absorption, boost the availability of plasma amino acids, and so enhance the postprandial response to muscle protein synthesis.
Enzymatic breakdown of the amide bond in proteins and peptides is known as proteolysis. The enzymes are used to carry out desired processing and analytical tasks as well as to speed up the transformation of raw materials into high-quality, more palatable foods. The majority of enzymes used in research and the food industry are hydrolases.
The use of proteolytic enzymes in the food business is well established, and they constitute the most economically significant group of enzymes. Researchers have paid a lot of attention to the use of proteases in the manufacture of fish protein hydrolysates because it is more convenient and less expensive. The characteristics of FPH (Fish Protein Hydrolysate) will depend on the type of enzymes, substrate, and hydrolysis.
Six out of every ten Americans deal with at least one chronic illness, such as cancer, diabetes, heart disease, or stroke. The main causes of death and disability in America are chronic diseases like these and others. Due to these, the demand for better healthcare facilities in the region is rising. Over the past ten years, there have been more new medications licensed each year. Between 2010 and 2019 (with a peak of 59 in 2018), the Food and Drug Administration (FDA) approved 38 new medications on average, which is 60% more than it did on an annual average over the preceding ten years.
The US market dominated the North America Protein Hydrolysis Enzymes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $813.9 million by 2028. The Canada market is poised to grow at a CAGR of 8.1% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.1% during (2022 - 2028).
Based on Source, the market is segmented into Plants, Animals, and Microorganisms. Based on Application, the market is segmented into Detergents, Pharmaceuticals, Food, Textiles & Leather, and Others. Based on Product, the market is segmented into Microbial Product (Alkaline Protease, Acid Protease, and Neutral Protease & Others), Plant Product (Papain, Bromelain & Others, Trypsin, Pepsin, and Renin & Others), and Animal Product (Trypsin, Pepsin, and Renin & Others). Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Protein Hydrolysis Enzymes Market is Estimated to reach $3.1 Billion by 2028, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novozymes A/S, Associated British Foods PLC (Wittington Investments Limited), Koninklijke DSM N.V., DuPont de Nemours, Inc., BASF SE, Advanced Enzyme Technologies Limited, Chr. Hansen Holding A/S, Dyadic International, Inc., Amano Enzyme, Inc., and Biocatalysts Limited (Brain AG).
By Source
By Application
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 